查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1968069

全球樹突細胞癌症疫苗市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Dendritic Cell Cancer Vaccine Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 112 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

樹突狀細胞癌疫苗市場預計將從 2025 年的 8.4 億美元成長到 2034 年的 24.3 億美元，2026 年至 2034 年的複合年成長率為 12.47%。

隨著免疫療法成為癌症治療的核心，樹突細胞癌疫苗的全球市場正日益受到關注。這些個人化疫苗能夠刺激免疫系統更有效地針對癌細胞。癌症發生率的上升和生物技術研究的進步正推動全球對創新療法的探索。

關鍵促進因素包括腫瘤學研究投入的增加、臨床試驗的擴大以及個人化醫療的普及。支持性的法規結構和細胞療法的技術進步正在加速產品開發。製藥公司與研究機構之間的合作正在加速商業化進程。

隨著免疫療法的突破性進展不斷改變癌症治療的模式，其未來前景仍然光明。生產流程的改進和擴充性的提升可望降低成本並提高可及性。在全球對精準醫療日益關注的背景下，樹突細胞疫苗預計將在下一代癌症治療中發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球樹突細胞癌症疫苗市場：依產品分類

  • 市場分析、洞察與預測
  • CreaVax
  • SippleCell-T
  • 其他

第5章：全球樹突細胞癌症疫苗市場：依最終用途分類

  • 市場分析、洞察與預測
  • 兒童
  • 成人

第6章 全球樹突細胞癌症疫苗市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Activartis Biotech GmbH
    • Batavia Bioservices BV
    • DanDrit Biotech
    • DCPrime
    • Elios Therapeutics
    • GlaxoSmithKline Plc
    • ImmunoCellular Therapeutics
    • Mendus
    • Northwest Biotherapeutics
    • Sanpower Corporation
簡介目錄
Product Code: VMR112110152

The Dendritic Cell Cancer Vaccine Market size is expected to reach USD 2.43 Billion in 2034 from USD 0.84 Billion (2025) growing at a CAGR of 12.47% during 2026-2034.

The Global Dendritic Cell Cancer Vaccine Market is gaining traction as immunotherapy becomes a central focus in cancer treatment. These personalized vaccines stimulate the immune system to target cancer cells more effectively. Increasing cancer prevalence and advancements in biotechnology research are driving interest in innovative therapeutic approaches worldwide.

Key drivers include rising investment in oncology research, growing clinical trials, and expanding adoption of personalized medicine. Supportive regulatory frameworks and technological progress in cell-based therapies are enhancing product development. Collaboration between pharmaceutical companies and research institutions is accelerating commercialization efforts.

The future outlook is optimistic as breakthroughs in immunotherapy continue to reshape cancer treatment paradigms. Advancements in manufacturing processes and improved scalability are expected to reduce costs and enhance accessibility. With growing global emphasis on precision medicine, dendritic cell vaccines are projected to play a significant role in next-generation oncology therapies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • CreaVax
  • Sipuleucel-T
  • Others

By End Use

  • Paediatrics
  • Adults

COMPANIES PROFILED

  • Activartis Biotech GmbH, Batavia Bioservices BV, DanDrit Biotech, DCPrime, Elios Therapeutics, GlaxoSmithKline plc, ImmunoCellular Therapeutics, Mendus, Northwest Biotherapeutics, Sanpower Corporation
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET: BY PRODUCT 2022-2034 (USD MN and Million Doses)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. CreaVax Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.3. Sipuleucel-T Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET: BY END USE 2022-2034 (USD MN and Million Doses)

  • 5.1. Market Analysis, Insights and Forecast End Use
  • 5.2. Paediatrics Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.3. Adults Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL DENDRITIC CELL CANCER VACCINE MARKET: BY REGION 2022-2034(USD MN and Million Doses)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 6.2.1 By Product
    • 6.2.2 By End Use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 6.3.1 By Product
    • 6.3.2 By End Use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 6.4.1 By Product
    • 6.4.2 By End Use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 6.5.1 By Product
    • 6.5.2 By End Use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 6.6.1 By Product
    • 6.6.2 By End Use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL DENDRITIC CELL CANCER VACCINE INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Activartis Biotech GmbH
    • 8.2.2 Batavia Bioservices B.V
    • 8.2.3 DanDrit Biotech
    • 8.2.4 DCPrime
    • 8.2.5 Elios Therapeutics
    • 8.2.6 GlaxoSmithKline Plc
    • 8.2.7 ImmunoCellular Therapeutics
    • 8.2.8 Mendus
    • 8.2.9 Northwest Biotherapeutics
    • 8.2.10 Sanpower Corporation